Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Float Short %

5.37

Margin Of Safety %

17

Put/Call OI Ratio

0.83

EPS Next Q Diff

0.04

EPS Last/This Y

9.43

EPS This/Next Y

0.68

Price

150.01

Target Price

152.93

Analyst Recom

2.63

Performance Q

-5.09

Relative Volume

0.52

Beta

1.5

Ticker: CRL




19 items of 1

DateSymbolLastP/C OIP/C VolTotal OI
2025-06-02CRL135.10.540.008657
2025-06-03CRL138.510.530.718780
2025-06-04CRL143.230.520.418871
2025-06-05CRL141.230.520.728981
2025-06-06CRL144.710.521.138996
2025-06-09CRL147.40.520.498994
2025-06-10CRL1510.5217.369229
2025-06-11CRL150.520.720.4310548
2025-06-12CRL151.880.720.2010620
2025-06-13CRL149.490.710.2810650
2025-06-16CRL151.060.710.0710647
2025-06-17CRL145.110.640.1311470
2025-06-18CRL145.260.610.3811800
2025-06-20CRL147.40.616.7311838
2025-06-23CRL147.410.900.507235
2025-06-24CRL148.440.900.087317
2025-06-25CRL150.340.850.137647
2025-06-26CRL151.540.831.037840
2025-06-27CRL150.040.831.357845
DateSymbolLastP/C OIP/C VolTotal OI
19 items Current Page1 of 1




19 items of 1

DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
2025-06-02CRL135.07-11.3453.69.62
2025-06-03CRL138.49-11.3466.39.62
2025-06-04CRL143.24-11.3470.29.62
2025-06-05CRL141.20-11.3449.29.62
2025-06-06CRL144.74-11.2466.29.62
2025-06-09CRL147.46-11.2463.79.62
2025-06-10CRL151.04-11.2466.09.62
2025-06-11CRL151.16-11.2455.89.62
2025-06-12CRL151.89-11.2457.69.62
2025-06-13CRL149.50-11.2448.49.62
2025-06-16CRL151.10-11.2460.29.62
2025-06-17CRL145.06-11.2437.99.63
2025-06-18CRL145.29-11.2456.19.63
2025-06-20CRL147.45-11.3461.99.62
2025-06-23CRL147.38-11.3455.29.62
2025-06-24CRL148.44-11.3458.59.62
2025-06-25CRL150.25-11.3460.89.62
2025-06-26CRL151.60-11.3459.39.63
2025-06-27CRL150.01-11.3450.89.63
DateTickerPriceCurrent Quarter Growth EstimateEBIT EstimationAverage EPS Estimate Current Year
19 items Current Page1 of 1




19 items of 1

DateTickerInsider TransactionsInstitutional TransactionsFloat Short
2025-06-02CRL0.441.185.69
2025-06-03CRL0.441.185.69
2025-06-04CRL0.441.185.69
2025-06-05CRL0.441.185.69
2025-06-06CRL0.441.185.69
2025-06-09CRL0.441.115.69
2025-06-10CRL0.401.115.69
2025-06-11CRL0.401.114.99
2025-06-12CRL0.401.114.99
2025-06-13CRL0.401.114.99
2025-06-16CRL0.391.114.99
2025-06-17CRL0.391.114.99
2025-06-18CRL0.391.114.99
2025-06-20CRL0.391.114.99
2025-06-23CRL0.391.094.99
2025-06-24CRL0.391.094.99
2025-06-25CRL0.391.094.99
2025-06-26CRL0.391.095.37
2025-06-27CRL0.391.095.37
DateTickerInsider TransactionsInstitutional TransactionsFloat Short
19 items Current Page1 of 1

Last Quarter Act. EPS

2.34

Avg. EPS Est. Current Quarter

2.48

Avg. EPS Est. Next Quarter

2.38

Insider Transactions

0.39

Institutional Transactions

1.09

Beta

1.5

Average Sales Estimate Current Quarter

984

Average Sales Estimate Next Quarter

960

Fair Value

175.26

Quality Score

52

Growth Score

60

Sentiment Score

54

Actual DrawDown %

67.4

Max Drawdown 5-Year %

-78.2

Target Price

152.93

P/E

Forward P/E

14.53

PEG

P/S

1.83

P/B

2.31

P/Free Cash Flow

13.08

EPS

-0.65

Average EPS Est. Cur. Y​

9.63

EPS Next Y. (Est.)

10.31

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

-0.78

Relative Volume

0.52

Return on Equity vs Sector %

-24.9

Return on Equity vs Industry %

-11.6

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

450.8
Charles River Laboratories Inte
Sector: Healthcare
Industry: Diagnostics & Research
Employees: 18700
Charles River Laboratories International, Inc. provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Assessment (DSA), and Manufacturing Solutions (Manufacturing). The RMS segment produces and sells rodents, and purpose-bred rats and mice for use by researchers. This segment also provides a range of services to assist its clients in supporting the use of research models in research and screening pre-clinical drug candidates, including research models, genetically engineered models and services, insourcing solutions, and research animal diagnostic services. The DSA segment offers early and in vivo discovery services for the identification and validation of novel targets, chemical compounds, and antibodies through delivery of preclinical drug and therapeutic candidates ready for safety assessment; and safety assessment services, such as toxicology, pathology, safety pharmacology, bioanalysis, drug metabolism, and pharmacokinetics services. The Manufacturing segment provides in vitro methods for conventional and rapid quality control testing of sterile and non-sterile pharmaceuticals and consumer products. This segment offers specialized testing of biologics that are outsourced by pharmaceutical and biotechnology companies. It utilizes Logica, a platform offering from Valo Health, to identify advanceable small molecule leads. It provides contract vivarium operation services to biopharmaceutical clients. The company was founded in 1947 and is headquartered in Wilmington, Massachusetts.
stock quote shares CRL – Charles River Laboratories International, Inc. Stock Price stock today
news today CRL – Charles River Laboratories International, Inc. stock forecast ,stock prediction 2023 2024 2025
marketwatch CRL – Charles River Laboratories International, Inc. yahoo finance google finance
stock history CRL – Charles River Laboratories International, Inc. invest stock market
stock prices CRL premarket after hours
ticker CRL fair value insiders trading